Health ❯Healthcare ❯Pharmaceuticals ❯Obesity Treatment

GLP-1 Drugs

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment